Tel: +44(0) 20 8560 2300

Resourcing Solutions for Medical Affairs, Regulatory Affairs and Clinical Development


News

In this section we publish latest news articles about AXESS. We also publish stories and features about the Medical, Regulatory and Clinical recruitment markets.

Compliance is most important consideration for 2012

axessweblogo

Feedback from users of interims and senior contractors within the pharmaceutical market has indicated that legal compliance is the most important feature that they require from their suppliers in 2012.  While service and technical knowledge are still important factors required from staffing suppliers, utter compliance to increasingly complex regulations in the sector has become the number one concern for pharmaceutical

More »

TOPRA Regulatory Affairs MSc lecture

topralogo

Paul Foster, Talent Acquisition Manager for AXESS, is passing on his expertise to students on the TOPRA Regulatory Affairs MSc course in Munich on 08 February 2012.  Paul is lecturing Module 10 of the MSc course, covering the Recruitment process and how to build effective teams within the Regulatory Affairs environment. This is the second year that he has lectured

More »

Clinical Development recruitment grows by 26%

axessweblogo

Despite the tough conditions within UK Clinical Development in 2011, AXESS, the Pharmaceutical industry recruitment specialist, reported a 26% increase in business within the Clinical Development recruitment sector during the year, with particular growth in senior management roles. To support this growth Rebecca Bray has been appointed as Talent Acquisition Manager focusing on Senior Clinical Development professionals.Commenting on the excellent

More »

AXESS Builds Team

axessweblogo

AXESS, the specialist Recruitment business is further strengthening its team. Omar de Bary joins as Talent Acquisition Specialist managing assignments in Clinical Development and Regulatory Affairs “Our business in Clinical Development continues to grow strongly – and Regulatory Affairs is a key focus for us,” says Ian Thomas, Managing Director. “We look for talented and experienced individuals when recruiting internally and Omar

More »

AXESS Steps Up in Scientific Affairs and Medical Liaison

AXESS Scientific Affairs

AXESS, the specialist Recruitment business is expanding its team.  Julia Day joins as Talent Acquisition Manager heading the Scientific Affairs Practice. “This area, which encompasses Medical Affairs Managers Medical Liaison, Scientific Advisors and Medical Information has been a real growth area for AXESS over the last few years,” says Ian Thomas, Managing Director. “Julia has been specialising in Medical and Scientific

More »

Understanding the MSL role

MSL article in Pipeline

AXESS provides a summary of  a presentation by Gillian Logan from Takeda about the Medical Science Liaison which was then published in PIPELINE, the magazine for members of the Pharmaceutical Information and Pharmacovigilance Association (PIPA). Key topics in the article include: There has been a 48% increase in the numbers of MSLs over the last 5 years. MSLs are NOT super-sales reps The role

More »

Job-hunting advice for PIPA

PIPA article

  Christian Simon, Talent Acquisition specialist at AXESS, gives advice and job-seeking tips in an article for PIPELINE, the magazine for members of the Pharmaceutical Information and Pharmacovigilance Association (PIPA). PIPA is the professional organisation for individuals in the pharmaceutical industry involved in the provision and management of information. The association was formed in 1974 and now represents over 800 members who

More »

AXESS bucks market with 12% growth

ianthomasphoto

AXESS, the Medical and Pharmaceutical industry recruitment specialist, celebrates its 20th year of trading reporting a 12% revenue growth in the year ended October 2010. This will be the 7th record year in a row for the Richmond based recruitment company which is a key supplier to a broad range of pharmaceutical and healthcare companies.Ian Thomas, Managing Director, comments "We

More »